Experimental and Therapeutic Medicine · 2015 · 19 citations · 21 references
PharmacyPharmacologyPharmacotherapyBiochemical PharmacologyPharmaceutical ToxicologyToxicodynamicsMolecular Mechanisms Of ToxicityNeuroprotectionOxidative Stress In InflammationPulmonary ToxicityPulmonary ToxicologyAntioxidant TreatmentDrug-induced Lung InjuryGlutathione Peroxidase ActivityOxidative Stress InjuryPulmonary Oxidative StressPulmonary Toxic InjurySerum Alanine AminotransferaseSerum Aspartate Aminotransferase
The aim of the present study was to assess the protective effect of silibinin against methotrexate (MTX)-induced pulmonary toxicity. Rats were divided into four groups (MTX, MTX + silibinin, silibinin and control. MTX was injected intraperitoneally (i.p) into female Wistar rats (10 mg/kg/day for 3 days), which resulted in significant increases in the serum levels of alanine aminotransferase, aspartate aminotransferase and oxidant enzymes, including nitric oxide and myeloperoxidase. Furthermore, significant reductions were detected in the serum activity levels of the antioxidative enzymes, glutathione peroxidase and superoxide dismutase, when compared with the control group. However, administration of silibinin (100 mg/kg/day for 10 days, i.p.) was shown to ameliorate the MTX-induced pulmonary toxicity, as indicated by the normalization of the oxidative stress parameters. Furthermore, silibinin treatment was demonstrated to reduce the histopathological changes associated with MTX. In conclusion, silibinin exhibited protective effects against MTX-induced pulmonary toxicity, which may be attributed to its antioxidant activity.
21
Melatonin prevents methotrexate‐induced hepatorenal oxidative injury in rats
Nermina Jahovic, Hülya Çevik, A. Özer Şehirli et al. · Journal of Pineal Research · 2003 · 245 citations
Pharmacy, Pharmacology, Toxicology +17
Silibinin protects mice from T cell-dependent liver injury☆
Jens Schümann, Jennifer Prockl, Alexandra K. Kiemer et al. · Journal of Hepatology · 2003 · 182 citations